Psoriatic arthritis is a heterogenous chronic inflammatory disease that develops over time in
some patients with psoriasis. The course of the disease is variable, with a broad clinical …

Psoriasis and psoriatic arthritis (PsA) development is sustained by tumor necrosis factor
(TNF) α, interleukin (IL) 17, and IL23; hence, biologics targeting those cytokines represent …

Background: Early identification of patients at risk of psoriatic arthritis (PsA) is essential to
facilitate early diagnosis and improve clinical outcomes. Severe cutaneous psoriasis has …

Patients with psoriasis are at risk of developing psoriatic arthritis, which can lead to
irreversible joint damage. However, a proportion of patients with psoriasis and concomitant …

Introduction Drugs and vaccines have been less studied as inducing or aggravating factors
for psoriatic arthritis (PsA) compared with psoriasis. Thus, the present study collected and …

Introduction To verify our hypothesis that psoriatic arthritis (PsA) is mainly genetically
predetermined and distinct from psoriasis (PsO), we use the TriNetX database to investigate …

Псориаз (ПсО)-хроническое иммуноопосредованное заболевание, в патогенезе
которого большую роль играют различные факторы риска (ФР) и генетическая …

Background. Psoriasis is a chronic systemic immune-inflammatory disease that affects not
only the skin, but also the musculoskeletal system. According to epidemiological and clinical …

Patients with psoriasis are at risk of developing psoriatic arthritis, which can lead to joint
damage. While screening questionnaires have been developed, their performance varies …

Цель исследования. Выполнить клинико-экономический анализ профиля пациента с
псориатическим артритом (ПсА) для актуализации данных по численности популяции …